For All The Latest Medical News, Health News, Research News, COVID-19 News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Cardiology News, Epigenetic News, Cancer News, Doctor News, Hospital News

BREAKING NEWS
Nikhil Prasad  Fact checked by:Thailand Medical News Team May 24, 2024  7 months, 1 day, 8 hours, 33 minutes ago

Herbs And Phytochemicals: Geraniin From Elaeocarpus Sylvestris Inhibits Herpes Simplex Virus-1

2742 Shares
facebook sharing button Share
twitter sharing button Tweet
linkedin sharing button Share
Herbs And Phytochemicals: Geraniin From Elaeocarpus Sylvestris Inhibits Herpes Simplex Virus-1
Nikhil Prasad  Fact checked by:Thailand Medical News Team May 24, 2024  7 months, 1 day, 8 hours, 33 minutes ago
Herbs And Phytochemicals: Herpes Simplex Virus-1 (HSV-1) affects approximately 70% of the human population, causing various health issues from oral herpes to severe encephalitis. Despite the availability of treatments like acyclovir, the emergence of drug-resistant strains of HSV-1 necessitates the discovery of new antiviral agents. Recent Herbs And Phytochemicals research by Kyung Hee University, GENENCELL Co., Ltd., and Sungkyunkwan University has uncovered a promising candidate: geraniin, derived from the tropical evergreen tree Elaeocarpus sylvestris var. ellipticus (ES). This study investigates the antiviral properties of geraniin and its potential as a new treatment for HSV-1.


Geraniin From Elaeocarpus Sylvestris Inhibits Herpes Simplex Virus-1

Discovery and Extraction of ESE50
Elaeocarpus sylvestris var. ellipticus, previously known for its antiviral effects against influenza A and SARS-CoV-2, was explored for its impact on HSV-1. Researchers extracted the plant at varying ethanol concentrations to determine the most effective form. The 50% ethanol extract (ESE50) emerged as the strongest inhibitor of HSV-1 replication, exhibiting an EC50 value of 23.2 μg/mL and low cytotoxicity (IC50 342.8 μg/mL). This balance of efficacy and safety marked ESE50 as a prime candidate for further investigation.
 
The Role of ICP0 in HSV-1 Replication
HSV-1 relies on the immediate-early protein ICP0 to initiate infection and reactivation from latency. This protein plays a crucial regulatory role, and its inhibition can significantly impair viral replication. The study focused on ESE50's impact on ICP0 expression in the lungs of HSV-1-infected mice. Results showed a marked decrease in ICP0 levels in treated mice, aligning with those treated with the control drug acyclovir.
 
Geraniin: The Active Compound
Upon isolating and analyzing ESE50, geraniin was identified as a key antiviral component. Using ESI-MS and 1D- and 2D-NMR, researchers confirmed geraniin's structure and its significant presence in the extract (132.16 μg/mg). Geraniin demonstrated potent antiviral activity in plaque reduction assays (EC50 8.3 μg/mL) and luciferase inhibition tests (EC50 36.9 μg/mL), reinforcing its potential as a powerful HSV-1 inhibitor.
 
Broad Spectrum Antiviral Properties
Geraniin's antiviral capabilities extend beyond HSV-1. This compound has shown effectiveness against human immunodeficiency virus (HIV), hepatitis B virus, and various other pathogens. Its diverse biological activities, including antioxidant, antimicrobial, and antitumor properties, make it a versatile candidate for therapeutic development.
 
Evaluating ESE50 and Geraniin
The study employed both in vitro and in vivo models to assess the antiviral effects of ESE50 and geraniin. In cell-based assays, ESE50 significantly reduced plaque formation and viral luciferase activity without compromising cell v iability. Similarly, geraniin markedly decreased HSV-1 replication, confirming its role as the active component in ESE50. These findings underscore geraniin's potential in controlling HSV-1 infection and highlight its safety profile in therapeutic applications.
 
Potential and Future Directions
ESE50 and geraniin present exciting prospects for new antiviral drugs, particularly against HSV-1. However, further research is essential to fully understand their mechanisms of action and broader applications. Clinical trials are needed to validate these findings in human subjects, and additional studies should explore geraniin's interactions with other viruses and its long-term efficacy.
 
Conclusion
The discovery of geraniin from Elaeocarpus sylvestris var. ellipticus as a potent inhibitor of HSV-1 replication marks a significant advancement in antiviral research. This compound, alongside ESE50, shows great promise for developing new treatments for HSV-1 and potentially other viral infections. The study's findings pave the way for future research and the eventual development of effective, novel antiviral therapies.
 
Final Thoughts
As the global health community continues to battle viral infections, the importance of discovering new antiviral agents cannot be overstated. The potential of natural products like geraniin offers hope for more effective and safer treatments. The promising results of this study encourage further exploration and development of herbal-based antivirals, which could revolutionize the way we approach and treat viral diseases in the future.
 
The study findings were published in the peer reviewed journal: Plants.
https://www.mdpi.com/2223-7747/13/11/1437
 
For the latest on Herbs And Phytochemicals, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/news/study-uncovers-how-human-astrocytes-fight-off-herpes-simplex-virus
 
https://www.thailandmedical.news/news/herbs-and-phytochemicals-polysaccharide-extracts-of-prunella-vulgaris-inhibits-herpes-simplex-virus-infection-by-blocking-tlr-mediated-nf-kb-activatio
 
https://www.thailandmedical.news/news/medical-news-columbia-university-study-shockingly-finds-that-herpes-simplex-2-infections-causes-brain-shrinkage-and-increases-risk-for-alzheimer-s-dis
 
https://www.thailandmedical.news/news/herbs-and-phytochemicals-wedelolactone-from-herbal-plants-eclipta-alba-and-wedelia-calendulacea-shows-promise-in-inhibiting-herpes-simplex-virus
 
https://www.thailandmedical.news/news/study-shows-that-post-covid-individuals-have-a-59-percent-risk-of-developing-herpes-zoster-or-shingles
 
https://www.thailandmedical.news/news/covid-19-news-spanish-researchers-warn-that-sars-cov-2-infections-and-vaccinations-trigger-reactivation-of-all-kinds-of-herpesviridae-viruses
 
https://www.thailandmedical.news/news/reactivation-of-herpes-hhv-6-and-ebv-is-associated-with-myalgic-encephalomyelitis-chronic-fatigue-syndrome-implications-for-long-covid
 
https://www.thailandmedical.news/news/breaking-covid-19-news-dormant-herpes-could-be-reactivated-by-covid-19-and-might-serve-as-an-indicator-of-latent-covid-19-infection-varied-implicatio
 
https://www.thailandmedical.news/news/breaking-danish-researchers-discover-how-viruses-avoid-immune-system--findings-could-help-develop-treatments-for-herpes,-flu-and-coronavirus
 
https://www.thailandmedical.news/news/herpes-research-study-on-how-the-hsv1-virus-can-evade-the-immune-system-to-infect-the-brain-could-shed-light-on-future-covid-19-treatments
 
https://www.thailandmedical.news/news/herpes-viruses-originated-from--africa,-the-continent-where-most-infectious-diseases-are-%E2%80%98born%E2%80%99
 
https://www.thailandmedical.news/news/herpes-virus-strain-hhv-6a--linked-to-multiple-sclerosis
 
https://www.thailandmedical.news/news/researchers-discover-inflammatory-protein-that-can-stop-herpes-virus-spread-
 
https://www.thailandmedical.news/news/urgent-need-for-more-research-studies-on-herpes--
 

MOST READ

Nov 26, 2024  29 days ago
Nikhil Prasad
Nov 19, 2024  1 month ago
Nikhil Prasad
Nov 05, 2024  2 months ago
Nikhil Prasad
Nov 05, 2024  2 months ago
Nikhil Prasad
Jul 25, 2024  5 months ago
Nikhil Prasad
Jul 24, 2024  5 months ago
Nikhil Prasad
Jun 10, 2023  2 years ago
COVID-19 News - DNA Methylation - Asymptomatic SARS-CoV-2 Infections
Aug 04, 2022  2 years ago
Source: Medical News - SARS-CoV-2 & Cancer